“...pleasure and pain, they come and go and don't last... bear them patiently”
—Gita
Pathos InvestmentsEquity Research
Research  ›  Fact Sheets  ›  WAT

WATERS CORP /DE/

LISTEDNYSE
SYMBOLWAT
SIC3826
STATE OF INC.DE
FISCAL YEAR ENDSDecember 31
CIK1000697

LABORATORY ANALYTICAL INSTRUMENTS · LARGE ACCELERATED FILER · 10 FISCAL YEARS OF SEC XBRL DATA, 2016–2025

REVENUES, NET INCOME AND FREE CASH FLOW BY FISCAL YEAR$ billions012342016201720182019202020212022202320242025RevenuesNet incomeFree cash flowEARNINGS AND DIVIDENDS PER SHARE$ per share0.005.0010.0015.002016201720182019202020212022202320242025EPS dilutedDividends per share

Fiscal years labelled by the calendar year in which they end. Bars in $ billions; per-share figures as reported.

CAPITALIZATION 12/31/25

($ millions)Amount%
Total debt1,41035.5
Stockholders' equity2,56164.5
Total capitalization3,971100.0

98,248,111 shares outstanding at 7 August 2026 (cover page of the 10-Q filed 11 August 2026).

LONG-TERM DEBT 12/31/25

($ millions)Amount
Long-term debt, incl. current maturities1,410
Long-term debt, noncurrent947

CAPITAL STOCK 12/31/25

Common shares authorized400,000,000
Common shares issued163,162,000
Treasury shares103,613,000
Par or stated value per share ($)0.01
Preferred stock ($ millions)0
Outstanding at 8/7/2698,248,111

DIVIDENDS DECLARED/PAID

Fiscal yearPer share $Payout %
2025––
2024––
2023––
2022––
2021––

HISTORY AND BUSINESS

HISTORY: Incorporated in Delaware.

BUSINESS: Classified by the SEC under Standard Industrial Classification 3826, Laboratory Analytical Instruments. Large accelerated filer. Principal executive office: 34 Maple St, Milford, MA 01757. Fiscal year ends December 31. For a description of the business, see Item 1 of the latest 10-K.

CONSOLIDATED INCOME ACCOUNT, YEARS ENDED

($ millions)12/31/2512/31/2412/31/23
Revenues3,1652,9582,956
Cost of revenues1,2891,2001,195
Research and development196183175
Selling, general and administrative830690736
Depreciation and amortization888785
Operating income803826818
Interest expense709099
Income before income taxes755755736
Income taxes11211794
Net income643638642
Earned per share, diluted ($)10.7610.7110.84
Dividends per share ($)–––

CONSOLIDATED BALANCE SHEET

($ millions)12/31/2512/31/24
Cash and equivalents588325
Receivables, net829733
Inventories572477
Total current assets2,1481,669
Property, plant and equipment, net642651
Goodwill1,3401,296
Total assets5,0774,554
Total current liabilities1,239790
Long-term debt9471,626
Total liabilities2,5152,725
Stockholders' equity2,5611,829
Total liabilities and equity5,0774,554

TEN-YEAR STATISTICS: FISCAL YEARS ($ millions except per share)

Fiscal year endedRevenuesOper. incomeNet incomeNet margin %EPS diluted $Div. per share $Oper. cash flowCapital expend.Free cash flowTotal assetsTotal liabilitiesTotal debtStockholders' equityROE %Debt / equity
12/31/253,16580364320.310.76–6531135405,0772,5151,4102,56125.10.55
12/31/242,95882663821.610.71–7621426204,5542,7251,6301,82934.90.89
12/31/232,95681864221.710.84–6031614424,6273,4772,3601,15055.82.05
12/31/222,97287370823.811.73–612––3,2812,7771,580504140.33.13
12/31/212,78682269324.911.17–747––3,0952,7271,520368188.54.14
12/31/202,36564552222.18.36–791––2,8402,6081,360232224.75.86
12/31/192,40770859224.68.69–643––2,5572,7731,685(216)-273.8-7.79
12/31/182,42074059424.57.65–604––3,7272,1601,1501,56737.90.73
12/31/172,309662200.90.25–698––5,3243,0912,0002,2340.90.90
12/31/162,16762552224.16.41–643––4,6622,3601,8302,30222.70.80

Net margin = net income ÷ revenues; ROE = net income ÷ year-end stockholders’ equity; total debt = long-term debt including current maturities plus short-term borrowings/commercial paper, as tagged in XBRL; free cash flow = operating cash flow − purchases of property, plant and equipment; d = derived as total assets − total equity where the filing does not tag total liabilities; – = not reported in XBRL for that year.

REGISTRANT:

WATERS CORP /DE/
CIK 1000697 · EIN 13-3668640

PRINCIPAL OFFICE:

34 Maple St, Milford, MA 01757
Tel.: 5084782000

INCORPORATED:

Delaware

INDUSTRY (SEC SIC CODE):

3826 · Laboratory Analytical Instruments

FILER STATUS:

Large accelerated filer

LATEST ANNUAL REPORT:

10-K for period ended 12/31/25, filed 23 February 2026

RECENT FILINGS (ANNUAL REPORT REFERENCES BELOW):

8/21/268-Kperiod 8/17/26
8/11/2610-Qperiod 7/4/26
8/4/268-Kperiod 8/4/26
5/22/268-Kperiod 5/21/26
5/12/2610-Qperiod 4/4/26
5/5/268-Kperiod 5/5/26
4/9/26DEF 14Aperiod 5/21/26
3/23/268-Kperiod 3/23/26

Sources: SEC XBRL company facts (all financial figures) · SEC submissions (registrant, address, SIC, filings) · annual reports: 10-K FY2025 (filed 2/23/26) · 10-K FY2024 (filed 2/25/25) · 10-K FY2023 (filed 2/27/24) · 10-K FY2022 (filed 2/27/23) · 10-K FY2021 (filed 2/24/22) · 10-K FY2020 (filed 2/24/21) · 10-K FY2019 (filed 2/25/20) · 10-K/A FY2018 (filed 3/1/19). Values are the latest figures filed for each fiscal year (restated where a later 10-K restated them). Ratios and free cash flow are Pathos calculations from those figures. Retrieved 31 October 2026.

Data from SEC filings. © 2026 Pathos Investments · pathosinvestments.com · For educational purposes only. Not investment advice.

Data from SEC filings  ·  Educational only  ·  Not investment advice